Enterprise Value
39.32M
Cash
21.68M
Avg Qtr Burn
-7.569M
Short % of Float
1.17%
Insider Ownership
41.86%
Institutional Own.
9.42%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
ELI-002 7P Details Pancreatic cancer, Cancer | Phase 1/2 Initiation | |
ELI-002 2P Details Solid tumor/s, Cancer | Phase 1 Update |